Challenges Ahead for Large Format Surgical Robotics
The news that J&J has decided to change their plans for a 510(k) pathway for it’s Verb-Auris general surgery robot should come as no surprise.
Large format surgical robotics is a damn difficult business.
– A CAPEX mindset when it comes to product development and sales pathway.
– Ongoing and aggressive product development.
– 100% ownership of the product roadmap. JV’s in robotics are near impossible to pull off.
– Deep pockets and a corporate structure that can tolerate large losses in the initial years of development and launch.
Internally, developing and launching large format surgical robotic platforms goes directly against their culture as well as a clear and present threat to their current revenue streams in their portfolios.
Many divergent stakeholders on their buses.
Buying a robotic platform does not make you a robotic culture. Fascinating challenges ahead.